SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3561 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1585FDA approves artificial retina: siliconinvestor.comDewDiligence_on_SI-2/14/2013
1584Agreed it at least til 2017 if not later (I believe it is 5 years from that dateFelix B-2/12/2013
1583Perhaps, but a buyout is a long way out. After 2017 in my view, if at all. TheBiotech Jim-2/12/2013
1582I think there setting up for an eventual buyout?Felix B-2/11/2013
1581REGN receives an HSR notice from SN that they intend to buy more REGN shares on Biotech Jim-2/11/2013
1580$136 and change was the most recent low, a few days ago, and look where we are tBiotech Jim-11/20/2012
1579REGN expands both jobs and production facility in upstate NY. timesunion.comBiotech Jim111/15/2012
1578US price of Zaltrap cut 50%: siliconinvestor.comDewDiligence_on_SI-11/8/2012
1577REGN Blowout earnings: investor.regeneron.com "Regeneron Reports Third QBiotech Jim-10/24/2012
1576AGN inks new DARPin collaboration with Molecular Partners: siliconinvestor.comDewDiligence_on_SI-8/21/2012
1575The question is can Trap (Zaltrap) penetrate cancer market? Sanofi was (is...???Miljenko Zuanic-8/20/2012
1574He was on earlier in the year (I believe when the company first became profitablFelix B-8/13/2012
1573This could be 'thanatos' or death wish for REGN, appearing with this guyBiotech Jim-8/13/2012
1572Hi Jim, I am in Croatia, so bit slow. Eylea sales are OK (standard surprise, goMiljenko Zuanic17/26/2012
1571Anyone paying attention to REGN and earnings today? I am sure Miljenko is! invBiotech Jim-7/26/2012
1570Novartis 2Q: ..., while revenue from Lucentis jumped 12 percent to $604 million.Miljenko Zuanic-7/20/2012
1569 ALN-PCS bloomberg.comMiljenko Zuanic-7/19/2012
1568How low will we go?Felix B-6/28/2012
1567Still not clear what will be path to REGN727 approval? They are repeating HeFH tMiljenko Zuanic-6/16/2012
1566Guess we will find out in another month or so....GLTA!!!!!!!!!!!!!Felix B-6/7/2012
1565Slots 07/24-25 are occupied. Appears there will not be Oncology AC for Zaltrap! Miljenko Zuanic-6/7/2012
1564ANG-2 rule? jci.orgMiljenko Zuanic-6/4/2012
1563Nice, where do you look up this info (I assume somewhere on FDA site). Like you Felix B-5/31/2012
1562July 24-25 is open slot for Oncology Drugs Advisory Committee. However, Zaltrap Miljenko Zuanic-5/31/2012
1561There probably will be, IMO.DewDiligence_on_SI-5/30/2012
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News